Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
16
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Seelenberger Alexander A. | See Remarks | 24 | $135.2K | $0 | 2024-08-12 |
| Izumi Raquel E. | See Remarks | 24 | $108.6K | $0 | 2024-08-12 |
| Hamdy Ahmed MD | See Remarks | 25 | $250.7K | $0 | 2024-08-12 |
| THOMAS TOM C | See Remarks | 25 | $46.0K | $0 | 2024-08-12 |
| Stevens Ruth E. | Director | 4 | $0 | $0 | 2024-05-23 |
| Lee John H. | Director | 6 | $10.2K | $0 | 2024-05-23 |
| Salva Francisco D. | Director | 5 | $0 | $0 | 2024-05-23 |
| Bushnell Laura I. | Director | 8 | $77.1K | $0 | 2024-05-23 |
| Druker Brian | Director | 6 | $0 | $0 | 2024-05-23 |
| LOWE CHRISTOPHER P. | Director | 7 | $175.7K | $0 | 2022-08-25 |
| McDonald Andrew I | Director, 10% Owner | 6 | $247.6K | $0 | 2022-05-26 |
| Zhang Xiaoming | Chief Technology Officer | 1 | $0 | $0 | 2022-02-14 |
| Hwang Sooin | Chief Business Officer | 3 | $36.3K | $0 | 2022-02-14 |
| Garban Hermes de Jesus | Chief Medical Officer | 2 | $0 | $0 | 2022-02-14 |
| Byrd John C. | 10% Owner | 1 | $0 | $0 | 2020-12-23 |
| McCamish Mark Anthony | Director | 1 | $0 | $0 | 2020-12-23 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Izumi Raquel E. | See Remarks | A Award deriv | 2024-08-12 | 2024-08-14 | 76,500 | — | $0 | 76,500 | SEC↗ |
| Izumi Raquel E. | See Remarks | D To issuer deriv | 2024-08-12 | 2024-08-14 | 90,000 | — | $0 | 0 | SEC↗ |
| Izumi Raquel E. | See Remarks | A Award deriv | 2024-08-12 | 2024-08-14 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Izumi Raquel E. | See Remarks | D To issuer deriv | 2024-08-12 | 2024-08-14 | 60,000 | — | $0 | 0 | SEC↗ |
| Izumi Raquel E. | See Remarks | A Award deriv | 2024-08-12 | 2024-08-14 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Izumi Raquel E. | See Remarks | D To issuer deriv | 2024-08-12 | 2024-08-14 | 60,000 | — | $0 | 0 | SEC↗ |
| Izumi Raquel E. | See Remarks | A Award deriv | 2024-08-12 | 2024-08-14 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Izumi Raquel E. | See Remarks | D To issuer deriv | 2024-08-12 | 2024-08-14 | 76,500 | — | $0 | 0 | SEC↗ |
| Izumi Raquel E. | See Remarks | A Award deriv | 2024-08-12 | 2024-08-14 | 41,250 | — | $0 | 165,000 | SEC↗ |
| Izumi Raquel E. | See Remarks | D To issuer deriv | 2024-08-12 | 2024-08-14 | 41,250 | — | $0 | 0 | SEC↗ |
| Izumi Raquel E. | See Remarks | A Award deriv | 2024-08-12 | 2024-08-14 | 123,750 | — | $0 | 123,750 | SEC↗ |
| Izumi Raquel E. | See Remarks | D To issuer deriv | 2024-08-12 | 2024-08-14 | 123,750 | — | $0 | 0 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | D To issuer deriv | 2024-08-12 | 2024-08-14 | 55,250 | — | $0 | 0 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | A Award deriv | 2024-08-12 | 2024-08-14 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | A Award deriv | 2024-08-12 | 2024-08-14 | 31,250 | — | $0 | 125,000 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | D To issuer deriv | 2024-08-12 | 2024-08-14 | 31,250 | — | $0 | 0 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | A Award deriv | 2024-08-12 | 2024-08-14 | 93,750 | — | $0 | 93,750 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | D To issuer deriv | 2024-08-12 | 2024-08-14 | 93,750 | — | $0 | 0 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | A Award deriv | 2024-08-12 | 2024-08-14 | 86,000 | — | $0 | 86,000 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | D To issuer deriv | 2024-08-12 | 2024-08-14 | 86,000 | — | $0 | 0 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | A Award deriv | 2024-08-12 | 2024-08-14 | 56,000 | — | $0 | 56,000 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | D To issuer deriv | 2024-08-12 | 2024-08-14 | 56,000 | — | $0 | 0 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | A Award deriv | 2024-08-12 | 2024-08-14 | 58,000 | — | $0 | 58,000 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | D To issuer deriv | 2024-08-12 | 2024-08-14 | 58,000 | — | $0 | 0 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | A Award deriv | 2024-08-12 | 2024-08-14 | 55,250 | — | $0 | 55,250 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | D To issuer deriv | 2024-08-12 | 2024-08-14 | 200,000 | — | $0 | 0 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | D To issuer deriv | 2024-08-12 | 2024-08-14 | 60,000 | — | $0 | 0 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | A Award deriv | 2024-08-12 | 2024-08-14 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | D To issuer deriv | 2024-08-12 | 2024-08-14 | 90,000 | — | $0 | 0 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | A Award deriv | 2024-08-12 | 2024-08-14 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | D To issuer deriv | 2024-08-12 | 2024-08-14 | 60,000 | — | $0 | 0 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | A Award deriv | 2024-08-12 | 2024-08-14 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | D To issuer deriv | 2024-08-12 | 2024-08-14 | 146,746 | — | $0 | 0 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | A Award deriv | 2024-08-12 | 2024-08-14 | 127,500 | — | $0 | 127,500 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | D To issuer deriv | 2024-08-12 | 2024-08-14 | 127,500 | — | $0 | 0 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | A Award deriv | 2024-08-12 | 2024-08-14 | 53,254 | — | $0 | 200,000 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | D To issuer deriv | 2024-08-12 | 2024-08-14 | 53,254 | — | $0 | 0 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | A Award deriv | 2024-08-12 | 2024-08-14 | 146,746 | — | $0 | 146,746 | SEC↗ |
| THOMAS TOM C | See Remarks | D To issuer deriv | 2024-08-12 | 2024-08-14 | 86,000 | — | $0 | 0 | SEC↗ |
| THOMAS TOM C | See Remarks | D To issuer deriv | 2024-08-12 | 2024-08-14 | 175,000 | — | $0 | 0 | SEC↗ |
| THOMAS TOM C | See Remarks | A Award deriv | 2024-08-12 | 2024-08-14 | 31,250 | — | $0 | 125,000 | SEC↗ |
| THOMAS TOM C | See Remarks | D To issuer deriv | 2024-08-12 | 2024-08-14 | 31,250 | — | $0 | 0 | SEC↗ |
| THOMAS TOM C | See Remarks | A Award deriv | 2024-08-12 | 2024-08-14 | 93,750 | — | $0 | 93,750 | SEC↗ |
| THOMAS TOM C | See Remarks | D To issuer deriv | 2024-08-12 | 2024-08-14 | 93,750 | — | $0 | 0 | SEC↗ |
| THOMAS TOM C | See Remarks | A Award deriv | 2024-08-12 | 2024-08-14 | 86,000 | — | $0 | 86,000 | SEC↗ |
| THOMAS TOM C | See Remarks | A Award deriv | 2024-08-12 | 2024-08-14 | 175,000 | — | $0 | 175,000 | SEC↗ |
| THOMAS TOM C | See Remarks | A Award deriv | 2024-08-12 | 2024-08-14 | 56,000 | — | $0 | 56,000 | SEC↗ |
| THOMAS TOM C | See Remarks | D To issuer deriv | 2024-08-12 | 2024-08-14 | 56,000 | — | $0 | 0 | SEC↗ |
| THOMAS TOM C | See Remarks | A Award deriv | 2024-08-12 | 2024-08-14 | 58,000 | — | $0 | 58,000 | SEC↗ |
| THOMAS TOM C | See Remarks | D To issuer deriv | 2024-08-12 | 2024-08-14 | 58,000 | — | $0 | 0 | SEC↗ |
| THOMAS TOM C | See Remarks | A Award deriv | 2024-08-12 | 2024-08-14 | 55,250 | — | $0 | 55,250 | SEC↗ |
| THOMAS TOM C | See Remarks | D To issuer deriv | 2024-08-12 | 2024-08-14 | 55,250 | — | $0 | 0 | SEC↗ |
| Bushnell Laura I. | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Stevens Ruth E. | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Lee John H. | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Salva Francisco D. | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Druker Brian | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | A Award deriv | 2024-05-23 | 2024-05-29 | 53,254 | — | $0 | 200,000 | SEC↗ |
| THOMAS TOM C | See Remarks | A Award deriv | 2024-05-23 | 2024-05-29 | 31,250 | — | $0 | 125,000 | SEC↗ |
| Izumi Raquel E. | See Remarks | A Award deriv | 2024-05-23 | 2024-05-29 | 41,250 | — | $0 | 165,000 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | A Award deriv | 2024-05-23 | 2024-05-29 | 31,250 | — | $0 | 125,000 | SEC↗ |
| THOMAS TOM C | See Remarks | A Award deriv | 2024-03-07 | 2024-03-08 | 93,750 | — | $0 | 93,750 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | A Award deriv | 2024-03-07 | 2024-03-08 | 146,746 | — | $0 | 146,746 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | A Award deriv | 2024-03-07 | 2024-03-08 | 93,750 | — | $0 | 93,750 | SEC↗ |
| Izumi Raquel E. | See Remarks | A Award deriv | 2024-03-07 | 2024-03-08 | 123,750 | — | $0 | 123,750 | SEC↗ |
| Seelenberger Alexander A. | See Remarks | P Buy | 2023-08-11 | 2023-08-14 | 10,500 | $0.95 | $10.0K | 30,280 | SEC↗ |
| Izumi Raquel E. | See Remarks | P Buy | 2023-08-10 | 2023-08-10 | 3,440 | $0.93 | $3.2K | 85,214 | SEC↗ |
| THOMAS TOM C | See Remarks | P Buy | 2023-08-10 | 2023-08-10 | 5,000 | $0.95 | $4.8K | 219,935 | SEC↗ |
| Hamdy Ahmed MD | See Remarks | P Buy | 2023-08-10 | 2023-08-10 | 5,400 | $0.96 | $5.2K | 96,060 | SEC↗ |
| Izumi Raquel E. | See Remarks | P Buy | 2023-08-09 | 2023-08-10 | 13,036 | $0.90 | $11.7K | 81,774 | SEC↗ |
| Hamdy Ahmed MD | See Remarks | P Buy | 2023-08-09 | 2023-08-10 | 16,900 | $0.95 | $16.1K | 90,660 | SEC↗ |
| Stevens Ruth E. | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Bushnell Laura I. | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Salva Francisco D. | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Druker Brian | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Lee John H. | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Izumi Raquel E. | See Remarks | A Award deriv | 2023-02-15 | 2023-02-16 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | A Award deriv | 2023-02-15 | 2023-02-16 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | A Award deriv | 2023-02-15 | 2023-02-16 | 86,000 | — | $0 | 86,000 | SEC↗ |
| THOMAS TOM C | See Remarks | A Award deriv | 2023-02-15 | 2023-02-16 | 86,000 | — | $0 | 86,000 | SEC↗ |
| THOMAS TOM C | See Remarks | P Buy | 2022-12-14 | 2022-12-14 | 7,000 | $0.83 | $5.8K | 10,000 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | P Buy | 2022-12-14 | 2022-12-14 | 35,280 | $0.87 | $30.7K | 73,760 | SEC↗ |
| Izumi Raquel E. | See Remarks | P Buy | 2022-12-14 | 2022-12-14 | 28,738 | $0.88 | $25.3K | 68,738 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | A Award deriv | 2022-11-15 | 2022-11-17 | 56,000 | — | $0 | 56,000 | SEC↗ |
| Izumi Raquel E. | See Remarks | A Award deriv | 2022-11-15 | 2022-11-17 | 60,000 | — | $0 | 60,000 | SEC↗ |
| THOMAS TOM C | See Remarks | A Award deriv | 2022-11-15 | 2022-11-17 | 56,000 | — | $0 | 56,000 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | A Award deriv | 2022-11-15 | 2022-11-17 | 60,000 | — | $0 | 60,000 | SEC↗ |
| THOMAS TOM C | See Remarks | A Award deriv | 2022-08-25 | 2022-08-29 | 58,000 | — | $0 | 58,000 | SEC↗ |
| Izumi Raquel E. | See Remarks | A Award deriv | 2022-08-25 | 2022-08-29 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | A Award deriv | 2022-08-25 | 2022-08-29 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | A Award deriv | 2022-08-25 | 2022-08-29 | 58,000 | — | $0 | 58,000 | SEC↗ |
| LOWE CHRISTOPHER P. | Director | P Buy | 2022-08-25 | 2022-08-26 | 11,600 | $1.65 | $19.1K | 40,000 | SEC↗ |
| LOWE CHRISTOPHER P. | Director | P Buy | 2022-08-24 | 2022-08-26 | 18,400 | $1.65 | $30.4K | 28,400 | SEC↗ |
| Izumi Raquel E. | See Remarks | P Buy | 2022-06-27 | 2022-06-29 | 40,000 | $1.41 | $56.4K | 40,000 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | P Buy | 2022-06-23 | 2022-06-27 | 24,200 | $1.41 | $34.1K | 38,480 | SEC↗ |
| Bushnell Laura I. | Director | P Buy | 2022-06-09 | 2022-06-13 | 15,000 | $1.91 | $28.6K | 19,202 | SEC↗ |
| McDonald Andrew I | Director, 10% Owner | A Award deriv | 2022-05-26 | 2022-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Bushnell Laura I. | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Stevens Ruth E. | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Lee John H. | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Druker Brian | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LOWE CHRISTOPHER P. | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Salva Francisco D. | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | A Award deriv | 2022-02-14 | 2022-02-16 | 55,250 | — | $0 | 55,250 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | A Award deriv | 2022-02-14 | 2022-02-16 | 127,500 | — | $0 | 127,500 | SEC↗ |
| Zhang Xiaoming | Chief Technology Officer | A Award deriv | 2022-02-14 | 2022-02-16 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Hwang Sooin | Chief Business Officer | A Award deriv | 2022-02-14 | 2022-02-16 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Izumi Raquel E. | See Remarks | A Award deriv | 2022-02-14 | 2022-02-16 | 76,500 | — | $0 | 76,500 | SEC↗ |
| THOMAS TOM C | See Remarks | A Award deriv | 2022-02-14 | 2022-02-16 | 55,250 | — | $0 | 55,250 | SEC↗ |
| Garban Hermes de Jesus | Chief Medical Officer | A Award deriv | 2022-02-14 | 2022-02-16 | 55,250 | — | $0 | 55,250 | SEC↗ |
| Hwang Sooin | Chief Business Officer | P Buy | 2021-12-23 | 2021-12-27 | 3,000 | $10.00 | $30.0K | 390,491 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | P Buy | 2021-12-22 | 2021-12-27 | 6,450 | $10.02 | $64.6K | 14,280 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | P Buy | 2021-12-22 | 2021-12-27 | 2,417 | $10.34 | $25.0K | 12,493 | SEC↗ |
| Bushnell Laura I. | Director | P Buy | 2021-12-22 | 2021-12-27 | 2,402 | $10.48 | $25.2K | 4,202 | SEC↗ |
| THOMAS TOM C | See Remarks | P Buy | 2021-12-22 | 2021-12-27 | 1,000 | $10.23 | $10.2K | 3,000 | SEC↗ |
| Izumi Raquel E. | See Remarks | P Buy | 2021-08-04 | 2021-08-06 | 1,000 | $11.96 | $12.0K | 1,000 | SEC↗ |
| Hwang Sooin | Chief Business Officer | P Buy | 2021-06-30 | 2021-06-30 | 500 | $12.66 | $6.3K | 385,575 | SEC↗ |
| LOWE CHRISTOPHER P. | Director | P Buy | 2021-06-30 | 2021-06-30 | 3,600 | $12.66 | $45.6K | 10,000 | SEC↗ |
| Bushnell Laura I. | Director | P Buy | 2021-06-30 | 2021-06-30 | 1,800 | $12.94 | $23.3K | 1,800 | SEC↗ |
| McDonald Andrew I | Director | P Buy | 2021-06-29 | 2021-07-01 | 20,000 | $12.38 | $247.6K | 20,000 | SEC↗ |
| Lee John H. | Director | P Buy | 2021-06-29 | 2021-07-01 | 799 | $12.72 | $10.2K | 799 | SEC↗ |
| THOMAS TOM C | See Remarks | P Buy | 2021-06-29 | 2021-06-30 | 2,000 | $12.58 | $25.2K | 2,000 | SEC↗ |
| LOWE CHRISTOPHER P. | Director | P Buy | 2021-06-29 | 2021-06-30 | 6,400 | $12.59 | $80.6K | 6,400 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | P Buy | 2021-06-29 | 2021-06-30 | 7,950 | $12.61 | $100.2K | 7,950 | SEC↗ |
| Hamdy Ahmed MD | Chief Executive Officer | P Buy | 2021-06-29 | 2021-06-30 | 7,830 | $12.77 | $100.0K | 7,830 | SEC↗ |
| Lee John H. | Director | A Award deriv | 2021-05-13 | 2021-05-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Stevens Ruth E. | Director | A Award deriv | 2021-05-13 | 2021-05-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Salva Francisco D. | Director | A Award deriv | 2021-05-13 | 2021-05-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Druker Brian | Director | A Award deriv | 2021-05-13 | 2021-05-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LOWE CHRISTOPHER P. | Director | A Award deriv | 2021-05-13 | 2021-05-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| McDonald Andrew I | Director, 10% Owner | A Award deriv | 2021-05-13 | 2021-05-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Bushnell Laura I. | Director | A Award deriv | 2021-05-13 | 2021-05-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| THOMAS TOM C | See Remarks | A Award deriv | 2021-03-15 | 2021-03-17 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Garban Hermes de Jesus | Chief Medical Officer | A Award deriv | 2021-03-01 | 2021-03-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| McDonald Andrew I | Director | J Other | 2021-01-28 | 2021-02-02 | 808,471 | — | $0 | 808,471 | SEC↗ |
| McDonald Andrew I | Director | J Other | 2021-01-28 | 2021-02-02 | 1,616,942 | — | $0 | 0 | SEC↗ |
| Bushnell Laura I. | Director | A Award deriv | 2020-12-23 | 2020-12-28 | 6,667 | — | $0 | 6,667 | SEC↗ |
| Druker Brian | Director | A Award deriv | 2020-12-23 | 2020-12-28 | 6,667 | — | $0 | 6,667 | SEC↗ |
| Salva Francisco D. | Director | A Award deriv | 2020-12-23 | 2020-12-28 | 6,667 | — | $0 | 6,667 | SEC↗ |
| McCamish Mark Anthony | Director | A Award deriv | 2020-12-23 | 2020-12-28 | 6,667 | — | $0 | 6,667 | SEC↗ |
| LOWE CHRISTOPHER P. | Director | A Award deriv | 2020-12-23 | 2020-12-28 | 6,667 | — | $0 | 6,667 | SEC↗ |
| Lee John H. | Director | A Award deriv | 2020-12-23 | 2020-12-28 | 6,667 | — | $0 | 6,667 | SEC↗ |
| McDonald Andrew I | Director | A Award deriv | 2020-12-23 | 2020-12-28 | 6,667 | — | $0 | 6,667 | SEC↗ |
| Seelenberger Alexander A. | Chief Financial Officer | A Award deriv | 2020-12-23 | 2020-12-28 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Byrd John C. | 10% Owner | A Award | 2020-12-23 | 2020-12-28 | 1,618,199 | — | $0 | 1,618,199 | SEC↗ |
| Druker Brian | Director | A Award | 2020-12-23 | 2020-12-28 | 54,806 | — | $0 | 54,806 | SEC↗ |
| Izumi Raquel E. | Chief Operations Officer | A Award | 2020-12-23 | 2020-12-28 | 1,618,199 | — | $0 | 1,618,199 | SEC↗ |
| Hamdy Ahmed MD | President and CEO | A Award | 2020-12-23 | 2020-12-28 | 1,618,199 | — | $0 | 1,618,199 | SEC↗ |